Item Type | Name |
Concept
|
Receptors, Antigen, B-Cell
|
Concept
|
HLA-A2 Antigen
|
Concept
|
Ki-1 Antigen
|
Concept
|
Prostate-Specific Antigen
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
Concept
|
Antigen Presentation
|
Concept
|
CA-19-9 Antigen
|
Concept
|
CA-125 Antigen
|
Concept
|
B7-H1 Antigen
|
Concept
|
CD11c Antigen
|
Concept
|
Proliferating Cell Nuclear Antigen
|
Concept
|
Ki-67 Antigen
|
Concept
|
HLA-B52 Antigen
|
Concept
|
Carcinoembryonic Antigen
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
HLA-A24 Antigen
|
Academic Article
|
Ring finger protein 43 as a new target for cancer immunotherapy.
|
Academic Article
|
Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice.
|
Academic Article
|
Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
|
Academic Article
|
Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis.
|
Academic Article
|
ADAM8 as a novel serological and histochemical marker for lung cancer.
|
Academic Article
|
Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese.
|
Academic Article
|
Prostate cancer genomics, biology, and risk assessment through genome-wide association studies.
|
Academic Article
|
HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.
|
Academic Article
|
Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cells.
|
Academic Article
|
Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.
|
Academic Article
|
Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
|
Academic Article
|
Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer.
|
Academic Article
|
[Phase I study of combination therapy with peptide vaccine and anti-cancer drug for colorectal cancer].
|
Academic Article
|
A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells.
|
Academic Article
|
Identification of an HLA-A2-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2).
|
Academic Article
|
Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma.
|
Academic Article
|
Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray.
|
Academic Article
|
Identification of SPARC as a candidate target antigen for immunotherapy of various cancers.
|
Academic Article
|
Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.
|
Academic Article
|
Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
|
Academic Article
|
FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling.
|
Academic Article
|
PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
|
Academic Article
|
Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer.
|
Academic Article
|
Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer.
|
Academic Article
|
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.
|
Academic Article
|
HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL.
|
Academic Article
|
Herpes simplex virus-induced, death receptor-dependent apoptosis and regression of transplanted human cancers.
|
Academic Article
|
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer.
|
Academic Article
|
Identification of HLA-A24-restricted novel T Cell epitope peptides derived from P-cadherin and kinesin family member 20A.
|
Academic Article
|
The current and future applications of immunopharmacogenomics.
|
Academic Article
|
Characterization of T-cell Receptor Repertoire in Inflamed Tissues of Patients with Crohn's Disease Through Deep Sequencing.
|
Academic Article
|
Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma.
|
Academic Article
|
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.
|
Academic Article
|
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors.
|
Academic Article
|
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.
|
Academic Article
|
Deep-sequencing of the T-cell receptor repertoire in patients with haplo-cord and matched-donor transplants.
|
Academic Article
|
Myasthenic crisis and polymyositis induced by one dose of nivolumab.
|
Academic Article
|
The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy.
|
Academic Article
|
Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.
|
Academic Article
|
Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study.
|
Academic Article
|
WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer.
|
Academic Article
|
Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection.
|
Academic Article
|
Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.
|
Academic Article
|
Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project.
|
Academic Article
|
Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.
|
Academic Article
|
Multiple therapeutic peptide vaccines for patients with advanced gastric cancer.
|
Academic Article
|
Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer.
|
Academic Article
|
Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
|
Academic Article
|
Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.
|
Academic Article
|
Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian Cancer.
|
Academic Article
|
Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer.
|
Academic Article
|
Characterization of the B-cell receptor repertoires in peanut allergic subjects undergoing oral immunotherapy.
|
Academic Article
|
Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations.
|
Academic Article
|
Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites.
|
Academic Article
|
CD8 lymphocytes in tumors and nonsynonymous mutational load correlate with prognosis of bladder cancer patients treated with immune checkpoint inhibitors.
|
Academic Article
|
Diversity in immunogenomics: the value and the challenge.
|
Academic Article
|
Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma.
|
Academic Article
|
Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides.
|
Academic Article
|
Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy.
|
Academic Article
|
One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication.
|
Academic Article
|
Characterization of double-negative T cells in colorectal cancers and their corresponding lymph nodes.
|